Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients With Progressive or Recurrent GBM

NCT00379470 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT00379470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00379470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients With Progressive or Recurrent GBM
Lead sponsor
NovoCure Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
January 31, 2011
Enrollment
236 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma multiforme